• To evaluate the outcomes of ventricular tachycardia (VT) ablation versus left ventricular assist device (LVAD) or heart transplantation (HT) in patients with severe heart failure (HF) and ventricular electric storm (ES).

Pugazhendhi Vijayaraman, MD, FHRS, Francesco Zanon, MD, FHRS, Shunmuga Sundaram Ponnusamy, MD, Bengt Herweg, MD, FHRS, Parikshit Sharma, MD, MPH, FHRS5, Manuel Molina-Lerma, MD, Marek Jastrzebski, MD, PhD, Zachary Whinnett, MD, PhD, Kevin Vernooy, MD, PhD,Rajeev K. Pathak, MBBS, PhD, Roderick Tung, MD, FHRS, Gaurav Upadhyay, MD, FHRS, Karol Curila, MD, PhD, Dipen Zalavadia, MD, Nischay Shah, MD, Lina Marcantoni, MD, Mohamed Gad, MD, Ramez Morcos, MD, Pawel Moskal, MD7, Akriti Naraen, MD, Mishal Mumtaz, MD, Jamario R. Skeete, MD, Praneet S. Katrapati, MD, Jeffrey Kolominsky, MD, Johan van Koll, MD, Mihail G. Chelu, MD, PhD, FHRS, Kenneth A. Ellenbogen, MD, FHRS, Oscar Cano, MD, PhD

Jason T. Jacobson, MD, FHRS, Westchester Medical Center, New York Medical College
T. Jared Bunch, MD, FHRS, University of Utah, School of Medicine
Dominik K Linz, MD, PhD, Maastricht University, Medical Center

ACE Disclosure Policy

The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.

Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.

ACCME Definition:

*An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Examples of such organizations include:

• Advertising, marketing, or communication firms whose clients are ineligible companies
• Bio-medical startups that have begun a governmental regulatory approval process
• Compounding pharmacies that manufacture proprietary compounds
• Device manufacturers or distributors
• Diagnostic labs that sell proprietary products
• Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
• Manufacturers of health-related wearable products
• Pharmaceutical companies or distributors
• Pharmacy benefit managers
• Reagent manufacturers or sellers

J. Jacobson: Honoraria/Speaking/Consulting: Zoll Medical, Abbott Medical, Vektor Medical, Stocks, Privately Held: Atlas 5D, Research: CardioFocus, Inc.

​Contributor Disclosure(s):
T. Bunch: Honoraria/Speaking/Consulting: Heart Rhythm Society, Pfizer, Inc, Research: Boehringer Ingelheim, Altathera, Abbott, Travel Costs: Biosense Webster
A. Desai: Nothing to disclose.